V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10369157 | 10064636 | 1.64 | 58.8 | Palliative (P) | 2018-06-09 | 2019-09-07 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 100429026 |
| 10369910 | 10064639 | 1.94 | 73.1 | Palliative (P) | 2017-02-06 | 2017-02-10 | Cabazitaxel | 99 | N | CABAZITAXEL | 101524358 |
| 10370151 | 10064641 | 1.55 | 56.3 | Palliative (P) | 2018-08-10 | 2018-09-15 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100082446 |
| 10370417 | 10064642 | 1.85 | 95 | Curative (C) | 2021-05-04 | 2021-05-04 | Cyclophosphamide Weekly PO | 02 | N | CYCLOPHOSPHAMIDE | 100486495 |
| 10370515 | 10064643 | 1.78 | 77.8 | null | 2019-04-30 | 2019-04-30 | Carboplatin + Liposomal Doxorubicin | 02 | null | IPILIMUMAB + NIVOLUMAB | 101859752 |
| 10370593 | 10064644 | 1.68 | 96.2 | 03 | 2018-02-04 | 2019-03-24 | GEMCITABINE | 99 | N | GEMCITABINE | 101250125 |
| 10370611 | 10064645 | 1.73 | 98.4 | Neo-adjuvant (N) | 2020-11-03 | 2021-06-24 | Melphalan IV High dose | 02 | N | MELPHALAN | 100966611 |
| 10370656 | 10064646 | 1.63 | 66.2 | null | 2021-02-24 | 2021-03-08 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 101836863 |
| 10370826 | 10064648 | 1.59 | 49.3 | Neo-adjuvant (N) | 2022-02-16 | 2022-02-16 | DABRAFENIB | 02 | N | ACALABRUTINIB | 100415103 |
| 10370832 | 10064649 | 1.69 | 95 | null | 2019-02-11 | 2019-07-20 | DABRAFENIB | 02 | null | CETUXIMAB | 101709998 |
| 10370954 | 10064650 | 1.59 | null | Palliative (P) | 2020-05-14 | 2020-05-19 | Cyclophosphamide oral | 02 | N | CYCLOPHOSPHAMIDE | 100383388 |
| 10371080 | 10064651 | 1.66 | 83.6 | 03 | 2018-10-29 | 2018-10-29 | Azacitidine | 02 | N | AZACITIDINE | 100708211 |
| 10371607 | 10064653 | 1.86 | 84 | null | 2019-07-15 | 2019-07-15 | MELPHALAN | 02 | null | MELPHALAN | 100704184 |
| 10371665 | 10064654 | 1.52 | 59.2 | Palliative (P) | 2019-01-06 | 2019-02-03 | Bortezomib (weekly) | 02 | N | BORTEZOMIB | 100496834 |
| 10371951 | 10064657 | 1.59 | 77.5 | Palliative (P) | 2020-02-23 | 2020-02-23 | CTD Attenuated (Thalidomide 50mg) | 02 | N | BORTEZOMIB + THALIDOMIDE | 100237364 |
| 10372296 | 10064659 | null | 68.8 | Not known (9) | 2017-09-16 | 2017-09-26 | Palbociclib | 02 | N | PALBOCICLIB | 101588932 |
| 10372545 | 10064662 | 1.76 | 85.88 | Palliative (P) | null | 2019-03-15 | Cabazitaxel | 02 | N | CABAZITAXEL | 101674853 |
| 10372614 | 10064664 | 1.82 | null | 03 | 2013-05-24 | 2016-09-14 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100242286 |
| 10372696 | 10064665 | 1.84 | 48.8 | null | 2019-01-18 | 2019-02-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DABRAFENIB | 100609012 |
| 10372860 | 10064666 | 1.52 | 70 | null | 2019-09-25 | 2019-12-20 | Vinorelbine IV | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101147460 |
| 10373066 | 10064667 | 1.58 | 76.4 | Palliative (P) | 2012-01-30 | 2020-06-01 | CISPLATIN + GEMCITABINE | 01 | N | ACALABRUTINIB | 100977109 |
| 10373347 | 10064669 | 1.63 | 81 | null | 2019-10-28 | 2020-12-04 | Cabazitaxel | 02 | null | CABAZITAXEL | 101222893 |
| 10373503 | 10064670 | 1.66 | 76.8 | null | 2019-09-22 | 2019-10-19 | DABRAFENIB | 2 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100235713 |
| 10373551 | 10064671 | 1.57 | null | null | 2019-06-25 | 2019-07-09 | CYCLOPHOSPHAMIDE | null | null | CYCLOPHOSPHAMIDE | 100660407 |
| 10373856 | 10064672 | 1.74 | 96 | Palliative (P) | 2019-05-09 | 2019-05-09 | Cabazitaxel | 02 | N | CABAZITAXEL | 100381016 |
| 10373928 | 10064674 | 1.87 | 87.3 | Palliative (P) | 2022-01-10 | 2022-01-10 | Capecitabine (21 day) + Irinotecan | 02 | N | ACALABRUTINIB | 100786051 |
| 10374243 | 10064677 | 1.57 | 70.3 | null | 2019-10-26 | 2019-10-26 | CHLORAMBUCIL + OBINUTUZUMAB | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 100520147 |
| 10374552 | 10064679 | 1.57 | 73.5 | Palliative (P) | 2020-06-08 | 2020-08-05 | Melphalan IV High dose | 02 | N | MELPHALAN | 100742557 |
| 10374578 | 10064680 | 1.52 | 86.4 | null | 2019-06-17 | 2019-06-17 | DABRAFENIB | 02 | null | CAPECITABINE + IRINOTECAN | 101131470 |
| 10374707 | 10064681 | 1.73 | 63.25 | null | 2020-08-20 | 2020-08-21 | GEMCITABINE | null | null | GEMCITABINE | 101668789 |
| 10374740 | 10064682 | 1.55 | 59.6 | Palliative (P) | 2014-08-03 | 2014-08-29 | Azacitidine | 02 | N | AZACITIDINE | 101676836 |
| 10374886 | 10064683 | 1.53 | null | Palliative (P) | 2019-10-14 | 2020-09-05 | GEMCITABINE | N | N | GEMCITABINE | 101053096 |
| 10374899 | 10064684 | 1.59 | 52 | null | 2022-02-05 | 2022-02-26 | BORTEZOMIB + THALIDOMIDE | 2 | null | BUSULFAN | 101121401 |
| 10374966 | 10064685 | 1.68 | 66.6 | Palliative (P) | 2018-12-14 | 2019-04-04 | Palbociclib | 02 | N | PALBOCICLIB | 101219231 |
| 10375040 | 10064686 | 1.63 | 118.5 | Curative (C) | 2021-03-09 | 2021-03-09 | Acalabrutinib | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100184254 |
| 10375153 | 10064687 | 1.85 | 65 | Palliative (P) | 2020-03-27 | 2020-03-27 | Chlorambucil | 02 | N | CHLORAMBUCIL | 101125657 |
| 10375896 | 10064691 | 1.65 | 56 | null | 2021-02-14 | 2021-05-22 | Melphalan IV High dose | 02 | null | MELPHALAN | 101489269 |
| 10376078 | 10064694 | 1.88 | 89.4 | Palliative (P) | 2020-08-07 | 2020-09-03 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100393346 |
| 10376546 | 10064695 | 1.55 | 57.8 | null | 2018-08-04 | 2018-08-04 | Cisplatin 7 day | 02 | null | IPILIMUMAB + NIVOLUMAB | 101359054 |
| 10378252 | 10064700 | 1.68 | 89 | null | 2019-07-15 | 2019-10-08 | Cetuximab 7 day (>Cycle 2) | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101203567 |
| 10378276 | 10064701 | 1.7 | 62.7 | Curative (C) | 2020-05-11 | 2020-05-11 | BORTEZOMIB + THALIDOMIDE | 02 | N | CISPLATIN + VINORELBINE | 100452186 |
| 10378984 | 10064706 | 1.59 | 96.6 | Curative (C) | 2022-04-22 | 2022-04-22 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100528358 |
| 10379044 | 10064707 | 1.69 | 74.9 | null | 2020-07-26 | 2020-08-28 | CABOZANTINIB | 02 | null | ACALABRUTINIB | 100876909 |
| 10379118 | 10064708 | 1.75 | 88.2 | 03 | 2018-12-13 | 2019-01-02 | CYCLOPHOSPHAMIDE | 02 | N | CYCLOPHOSPHAMIDE | 101454984 |
| 10379136 | 10064709 | null | 82.3 | null | null | 2019-01-30 | PERTUZUMAB + TRASTUZUMAB | 02 | null | CHLORAMBUCIL | 101684977 |
| 10379346 | 10064710 | 1.55 | 67 | null | 2018-08-05 | 2018-08-14 | AFATINIB | 02 | null | AFATINIB | 101822681 |
| 10379510 | 10064713 | 1.58 | 93.6 | Palliative (P) | 2022-04-09 | 2022-04-16 | null | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100250244 |
| 10379717 | 10064715 | 1.76 | 57.8 | Palliative (P) | 2018-05-17 | 2018-06-22 | Palbociclib | 02 | N | PALBOCICLIB | 100925496 |
| 10379774 | 10064717 | null | 71 | null | 2019-05-18 | 2019-06-05 | DABRAFENIB | 02 | null | CABOZANTINIB | 101333127 |
| 10380023 | 10064719 | 1.82 | 70 | 03 | 2022-04-01 | 2022-04-05 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | N | CYCLOPHOSPHAMIDE | 100643928 |